0LSZ Stock Overview
Operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 2/6 |
Walgreens Boots Alliance, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$15.91 |
| 52 Week High | US$31.78 |
| 52 Week Low | US$14.62 |
| Beta | 0.77 |
| 11 Month Change | -1.09% |
| 3 Month Change | -22.79% |
| 1 Year Change | -49.78% |
| 33 Year Change | -69.39% |
| 5 Year Change | -70.80% |
| Change since IPO | -79.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0LSZ | GB Consumer Retailing | GB Market | |
|---|---|---|---|
| 7D | 3.8% | -0.8% | 1.1% |
| 1Y | -49.8% | 20.7% | 8.1% |
Return vs Industry: 0LSZ underperformed the UK Consumer Retailing industry which returned 20.7% over the past year.
Return vs Market: 0LSZ underperformed the UK Market which returned 8.1% over the past year.
Price Volatility
| 0LSZ volatility | |
|---|---|
| 0LSZ Average Weekly Movement | 6.3% |
| Consumer Retailing Industry Average Movement | 3.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0LSZ's share price has been volatile over the past 3 months.
Volatility Over Time: 0LSZ's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1909 | 268,500 | Tim Wentworth | www.walgreensbootsalliance.com |
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S.
Walgreens Boots Alliance, Inc. Fundamentals Summary
| 0LSZ fundamental statistics | |
|---|---|
| Market cap | US$13.78b |
| Earnings (TTM) | -US$6.04b |
| Revenue (TTM) | US$144.60b |
0.1x
P/S Ratio-2.3x
P/E RatioIs 0LSZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0LSZ income statement (TTM) | |
|---|---|
| Revenue | US$144.60b |
| Cost of Revenue | US$117.72b |
| Gross Profit | US$26.88b |
| Other Expenses | US$32.91b |
| Earnings | -US$6.04b |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
Jun 27, 2024
| Earnings per share (EPS) | -7.00 |
| Gross Margin | 18.59% |
| Net Profit Margin | -4.18% |
| Debt/Equity Ratio | 61.7% |
How did 0LSZ perform over the long term?
See historical performance and comparison